Bursa rejects appeal by Pharmaniaga


PETALING JAYA: Bursa Malaysia has dismissed financially distressed Pharmaniaga Bhd’s appeal to undertake a second standalone private placement proposal.

In a filing with Bursa Malaysia, the Practice Note 17 company said Bursa Malaysia had vide its letter dated Sept 13, 2023, dismissed its appeal submitted on Aug 1, 2023 to undertake the second proposed private placement after taking into consideration the relevant facts and circumstances.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

SD Guthrie nine-month profit rises
MARC Ratings upgrades Johor Port to AAIS
Higher gas tariffs likely to squeeze glovemakers’ third-quarter profit
IOI’s maiden RE foray seen to unlock land bank value
Pentamaster’s 3Q profit up to RM20.44mil
Sunway-REIT on track to reach new AUM target
Sentral-REIT’s quarterly results improve
Rosado inks underwriting deal for ACE Market IPO
BNM keeps interest rates unchanged
Naga 3 likely to improve Velesto’s bottom line

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read